# Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/developing-and-submitting-proposed-draft-guidance-relating-to-patient-experience-data/49677313-1014-4cd6-be89-f28a08eb3f96

> FDA guidance document: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data. Issue date: December 21, 2018. Get complete insights and analysis.

---

## Details

- Title: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-12-21
- Comment Close Date: 2019-03-21
- Last Changed: 2020-04-23
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-4455">FDA-2018-D-4455</a>

## Related Documents

- [Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/real-world-evidence-considerations-regarding-non-interventional-studies-for-drug-and-biological-products/48325e39-b445-4a53-8cc0-7483dcf3e352)
- [Considerations for Complying with 21 CFR 211110](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-complying-with-21-cfr-211110/3d80c8ad-a552-4ac0-9f33-3581f781f0c3)
- [Neovascular Age-Related Macular Degeneration: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/neovascular-age-related-macular-degeneration-developing-drugs-for-treatment/3b32c08c-4e69-42f4-ba19-cda20a8af050)